Aptium Oncology, Inc.

Aptium Oncology, Inc.

Aptium Oncology, Inc.

Date Founded



4607 Lakeview Canyon Road,Suite 260,Westlake Village, CA 91361

Type of Company



Hospitals & Patient Services

Company Description

Aptium Oncology, Inc. designs, builds, and manages cancer care centers. The firm manages hospital-based, outpatient, and cancer treatment centers for patients with all types of cancer, as well as operating 24-hour cancer treatment centers in hospitals. The company was founded in 1983 and is headquartered in Westlake Village, CA.

Contact Data
Trying to get in touch with decision makers at Aptium Oncology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
The Daily Telegraph (London)
January 23, 2017
The simple cocktail that fights cancer...
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Executive Vice President & General Counsel

Chief Information Officer

Chief Medical Officer

Director-Marketing & Public Relations

Director of Laboratory

Executive Vice President-Business Development & Consulting

Vice President, Clinical Systems & Knowledge Management

Research Analyst

Paths to Aptium Oncology, Inc.
Potential Connections via
Relationship Science
Aptium Oncology, Inc.
Recent Transactions
Details Hidden

Gambro AB, Gambro Healthcare, Inc. purchase USHAWL & Century Dialysis /12 Dialysis Clinics from Aptium Oncology, Inc.

Details Hidden

AstraZeneca Plc purchases Aptium Oncology, Inc.

Details Hidden

Zeneca Group Plc purchases Aptium Oncology, Inc.

Non-Profit Donations & Grants
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aptium Oncology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aptium Oncology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aptium Oncology, Inc..